Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study.
Conclusions: It was feasible to measure cfDNA concentration. Despite the limited cohort size, there was a good tendency between cfDNA and treatment course and -response, respectively with the highest levels at progression.
PMID: 31320993 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Clinical Trials | Immunotherapy | Neurology | Study | Temodar